US Patent Issued to BIKA BIOTECHNOLOGY (GUANGZHOU) on Sept. 16 for "Docetaxel composition for injection and preparation method therefor" (Chinese Inventor)

ALEXANDRIA, Va., Sept. 17 -- United States Patent no. 12,414,914, issued on Sept. 16, was assigned to BIKA BIOTECHNOLOGY (GUANGZHOU) Co. LTD (Guangzhou, China).

"Docetaxel composition for injection and preparation method therefor" was invented by Yingting Xu (Guangzhou, China).

According to the abstract* released by the U.S. Patent & Trademark Office: "A docetaxel composition for injection and a preparation method therefor. The composition comprises the following components in parts by weight: 1 part of docetaxel, 20-60 parts of cyclodextrin, 5-80 parts of a solubilizer, 10-20 parts of stabilizer 1, 0.2-30 parts of stabilizer 2, and 0.001-1.0 part of an additive. The composition does not comprise ethanol and polysorbate, and ethanol is no...